Nanda, Amit
Kabra, Rajesh
Article History
First Online: 10 December 2019
Compliance with Ethical Standards
:
: Amit Nanda declares no potential conflicts of interest. Rajesh Kabra has licensed technologies from Icahn School of Medicine at Mount Sinai to Rx. Health Digital Therapeutics Prescribing Platform. Dr. Kabra is the section editor of the Arrhythmia section of <i>Current Treatment Options in Cardiovascular Medicine</i>.
: This article does not contain any studies with human or animal subjects performed by any of the authors.